Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
SHZ: 300357.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Jianming He
- Employees
- 1,679
- Headquarters
- Huzhou, China
- IPO year
- 2014
- Market cap
- CN¥13.2B
- Website
- https://www.wolwobiotech.com
Loading 300357…
Loading profile data…Frequently asked questions about 300357
What does Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) do?
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and sells pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. It also offers skin care and stem cells series. The company is headquartered in Huzhou, China.
Where does 300357.SZ trade?
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300357.SZ in?
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.?
Jianming He is the chief executive officer of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ).
Where is Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. headquartered?
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is headquartered in China.
Does 300357.SZ pay a dividend?
Yes — Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) paid a trailing twelve-month dividend of CNY 0.22 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300357.SZ go public?
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) completed its initial public offering in 2014.